drugset / Trial / NCT00890032
Vaccine Therapy in Treating Patients Undergoing Surgery for Recurrent Glioblastoma Multiforme
NaSingle-groupOpen-labelTreatment
Summary
RATIONALE: Vaccines made from a person's tumor cells and dendritic cells may help the body build an effective immune response to kill tumor cells. PURPOSE: This phase I trial is studying the side effects of vaccine therapy in treating patients undergoing surgery for recurrent glioblastoma multiforme (GBM).
Timeline
- Start
- 2009-09
- Primary completion
- 2014-10
- Completion
- 2016-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BTSC mRNA-loaded DCs | Vaccine | 2e+06 cells | Other |
| Subject | BTSC mRNA-loaded DCs | Vaccine | 5e+06 cells | Other |
| Subject | BTSC mRNA-loaded DCs | Vaccine | 2e+07 cells | Other |